Abacavir/Lamivudine 600/300 APOTEX

Abacavir/Lamivudine 600/300 APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABACAVIR/LAMIVUDINE 600/300 APOTEX TABLET Contains the active ingredients abacavir (as sulfate) and lamivudine Consumer Medicine Information PATIENTS TAKING ABACAVIR AND LAMIVUDINE COMBINATION TABLETS, WHICH CONTAINS ABACAVIR, MAY…

Read More
Buvidal Monthly

Buvidal Monthly

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BUVIDALĀ® Buprenorphine Consumer Medicine Information Warning: Risk of Serious Harm or Death with Intravenous Administration Serious harm or death could result if administered intravenously.  Buvidal Monthly forms…

Read More
APO-Amisulpride

APO-Amisulpride

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-AMISULPRIDE Amisulpride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about amisulpride. It does not contain all the available information. It…

Read More